Morning Report: Faron Pharma expands MATINS trial to include ovarian cancer

Headlines from the Proactive UK newsroom.

Faron Pharmaceuticals (LON:FARN) is to expand its phase I/II MATINS clinical trial of its Clevegen cancer drug to women with ovarian cancer. Earlier this month, Faron was also given permission to expand the ongoing trial into late-stage colorectal cancer.

AFC Energy (LON:AFC) has signed a heads of agreement to collaborate with a hydrogen extraction specialist. The green hydrogen produced from their technology is a potential fuel source for AFC Energy's H-Power fuel cell systems.

Pawnbroker H&T (LON:HAT) expects results in 2019 to be at the top end of market expectations. Second half trading was strong with good performances from the acquired Money Shop and Speedloan assets.

Amigo Loans (LON:AMGO) is up for sale after its controlling shareholder said it wants to sell its 60% stake. The strategic review will consider sales of part or all of the guaranteed lender business.

Halma (LON:HLMA) has beefed up its medical arm with the acquisition of US bone graft manufacturer NovaBone for US$97mln. The Florida-based group’s revenues in 2019 were US$21mln.

Two AstraZeneca drugs have passed their latest clinical trials. Brilinta reduced the risk of further complications or death when combined with aspirin in early stage stroke sufferers while Enhertu met its survival endpoint in a phase II trial for gastric cancer.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Faron Pharmaceuticals Ltd named herein, including the promotion by the Company of Faron Pharmaceuticals Ltd in any Content on the Site, the...


ImagineAR signs two year deal with Valencia FC to bring Augmented Reality to...

ImagineAR (CSE: IP-OTCQB: IPNFF) CEO Alen Paul Silverrstieen and Valencia Chief Digital Innovation Officer Franco Segarra joined Steve Darling from Proactive to bring news the company has signed a two-year partnership agreement with Valencia FC, one of the biggest soccer clubs in the world and...

9 minutes ago

2 min read